This text discusses various studies and trials related to individualized dosing of fluoropyrimidine therapy in cancer patients, adjuvant therapy for colon cancer, duration of oxaliplatin-based therapy, follow-up strategies for non-metastatic colorectal cancer, advanced imaging for colorectal neoplasia detection, and different treatment options for high-risk stage II and III colon cancers.